EXE: third-quarter growth and disciplined leverage support expansion plans
According to TradingView, EXE's adjusted EBITDA rose 41% year over year, with leverage at 2.3x. Construction costs and funding timing remain the key risks.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, EXE's adjusted EBITDA for the third quarter rose 41% year over year. The growth was supported mainly by CBI and organic expansion in its home health business.
The company reports strong liquidity and leverage of 2.3x, which gives it room for M&A and redevelopment projects. Construction costs and the timing of funding remain the main uncertainties.
why it matters
For investors, faster earnings growth and moderate debt create a buffer, but higher building costs and delays in financing could slow the company's expansion plans.
market impact
EXE shares: strong EBITDA growth supports sentiment around the company
- EXE shares pressure up — faster third-quarter adjusted EBITDA growth strengthens the financial picture
tags
instruments
sources
- EXE: Q3 growth and disciplined leverage underpin expansion, despite funding and construction uncertainty — TradingView, 6 November 2026 at 19:35 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗